Mandi Jocelyn Schwartz was a Canadian ice hockey player with the Yale Bulldogs.
18 Facts About Mandi Schwartz
1.
2.
Mandi Schwartz was a three time Eastern College Athletic Conference Hockey All-Academic, and played 73 consecutive games with the team before being diagnosed with acute myeloid leukemia in December 2008.
3.
Mandi Schwartz underwent a stem cell transplant from donated umbilical cord blood in September 2010.
4.
Mandi Schwartz died in Regina, Saskatchewan, at the age of 23.
5.
Mandi Schwartz played minor hockey at Athol Murray College of Notre Dame in Wilcox, Saskatchewan, and served as team captain.
6.
Mandi Schwartz attended evaluation camps for Canadian national women's ice hockey team hosted by Hockey Canada.
7.
Mandi Schwartz joined the Yale Bulldogs after graduating high school in 2006.
8.
Mandi Schwartz played 2 full seasons and part of a third at Yale University, before being diagnosed with leukemia.
9.
Mandi Schwartz was an ECAC Hockey All-Academic during the three seasons she played.
10.
At the start of her junior season, Mandi Schwartz had played in 11 games before being diagnosed with leukemia.
11.
Mandi Schwartz tallied one assist during those games, but seemed to be struggling with her endurance, despite being in excellent shape.
12.
Mandi Schwartz was initially diagnosed with anemia, but received the diagnosis of acute myeloid leukemia the following day.
13.
Mandi Schwartz was diagnosed with acute myeloid leukemia in December 2008, during her junior year at Yale.
14.
Mandi Schwartz had been sick for much of the fall semester, but attributed it to stress and an initial diagnosis of anemia.
15.
Mandi Schwartz started treatment for her cancer in December 2008 and was able to briefly return to school and began practicing with the hockey team again in January 2010.
16.
Mandi Schwartz's cancer went into remission after the transplant, but returned again in December 2010.
17.
Shortly after this, Mandi Schwartz decided to discontinue most forms of treatment.
18.
Rather than hoping for a cure, Mandi Schwartz continued with palliative chemotherapy designed to minimize her symptoms.